{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:12:03Z","timestamp":1760854323666,"version":"3.37.3"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T00:00:00Z","timestamp":1699315200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s12328-023-01886-8","type":"journal-article","created":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T10:01:49Z","timestamp":1699351309000},"page":"12-17","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Gastric cancer with Fanconi anemia in adolescent and young adult patient diagnosed by comprehensive genome profiling using next-generation sequencing"],"prefix":"10.1007","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8971-404X","authenticated-orcid":false,"given":"Tsutomu","family":"Namikawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaya","family":"Munekage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromichi","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Kurioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironaga","family":"Satake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michiya","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Hanazaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,11,7]]},"reference":[{"key":"1886_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"1886_CR2","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.puhe.2022.06.010","volume":"210","author":"J Li","year":"2022","unstructured":"Li J, Kuang XH, Zhang Y, et al. Global burden of gastric cancer in adolescents and young adults: estimates from GLOBOCAN 2020. Public Health. 2022;210:58\u201364.","journal-title":"Public Health"},{"key":"1886_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-061038","volume":"12","author":"SL Wu","year":"2022","unstructured":"Wu SL, Zhang Y, Fu Y, et al. Gastric cancer incidence, mortality and burden in adolescents and young adults: a time-trend analysis and comparison among China, South Korea, Japan and the USA. BMJ Open. 2022;12: e061038.","journal-title":"BMJ Open"},{"key":"1886_CR4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1002\/humu.23366","volume":"39","author":"DC Kimble","year":"2018","unstructured":"Kimble DC, Lach FP, Gregg SQ, et al. A comprehensive approach to identification of pathogenic FANCA variants in Fanconi anemia patients and their families. Hum Mutat. 2018;39:237\u201354.","journal-title":"Hum Mutat"},{"key":"1886_CR5","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/j.molcel.2018.06.030","volume":"71","author":"A Benitez","year":"2018","unstructured":"Benitez A, Liu W, Palovcak A, et al. FANCA promotes DNA double-strand break repair by catalyzing single-strand annealing and strand exchange. Mol Cell. 2018;71:621-8.e4.","journal-title":"Mol Cell"},{"key":"1886_CR6","doi-asserted-by":"publisher","first-page":"829","DOI":"10.3390\/cancers12040829","volume":"12","author":"J Del Valle","year":"2020","unstructured":"Del Valle J, Rofes P, Moreno-Cabrera JM, et al. Exploring the role of mutations in Fanconi anemia genes in hereditary cancer patients. Cancers (Basel). 2020;12:829.","journal-title":"Cancers (Basel)"},{"key":"1886_CR7","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.16304","author":"K Ishikawa","year":"2023","unstructured":"Ishikawa K, Ishiwatari H, Sasaki K, et al. Optimization of endoscopic ultrasound-guided tissue sample acquisition for commercially available comprehensive genome profiling. J Gastroenterol Hepatol. 2023. https:\/\/doi.org\/10.1111\/jgh.16304.","journal-title":"J Gastroenterol Hepatol"},{"key":"1886_CR8","doi-asserted-by":"publisher","first-page":"280","DOI":"10.3390\/genes14020280","volume":"14","author":"A Nurgalieva","year":"2023","unstructured":"Nurgalieva A, Galliamova L, Ekomasova N, et al. Whole exome sequencing study suggests an impact of FANCA, CDH1 and VEGFA genes on diffuse gastric cancer development. Genes (Basel). 2023;14:280.","journal-title":"Genes (Basel)"},{"key":"1886_CR9","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.cell.2022.01.003","volume":"185","author":"B Nguyen","year":"2022","unstructured":"Nguyen B, Fong C, Luthra A, et al. Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients. Cell. 2022;185:563-75.e11.","journal-title":"Cell"},{"key":"1886_CR10","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1007\/s00277-002-0546-4","volume":"81","author":"K Pavithran","year":"2002","unstructured":"Pavithran K, Ajithkumar BV, Roy D, et al. Adenocarcinoma of the stomach in Fanconi\u2019s anemia. Ann Hematol. 2002;81:666\u20137.","journal-title":"Ann Hematol"},{"key":"1886_CR11","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00439-011-0951-7","volume":"129","author":"MR Akbari","year":"2011","unstructured":"Akbari MR, Malekzadeh R, Lepage P, et al. Mutations in Fanconi anemia genes and the risk of esophageal cancer. Hum Genet. 2011;129:573\u201382.","journal-title":"Hum Genet"},{"key":"1886_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1055\/s-0042-1751303","volume":"9","author":"P Sharma","year":"2022","unstructured":"Sharma P, Sharma N, Sharma D. A narrative review on Fanconi anemia: genetic and diagnostic considerations. Glob Med Genet. 2022;9:237\u201341.","journal-title":"Glob Med Genet"},{"key":"1886_CR13","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/S0140-6736(20)31607-X","volume":"396","author":"A Lleo","year":"2020","unstructured":"Lleo A, Wang GQ, Gershwin ME, et al. Primary biliary cholangitis. Lancet. 2020;396:1915\u201326.","journal-title":"Lancet"},{"key":"1886_CR14","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1038\/jid.2014.416","volume":"135","author":"J Yin","year":"2015","unstructured":"Yin J, Liu H, Liu Z, et al. Genetic variants in Fanconi anemia pathway genes BRCA2 and FANCA predict melanoma survival. J Invest Dermatol. 2015;135:542\u201350.","journal-title":"J Invest Dermatol"},{"key":"1886_CR15","doi-asserted-by":"publisher","first-page":"5788","DOI":"10.1158\/1078-0432.CCR-13-1217","volume":"19","author":"W Dai","year":"2013","unstructured":"Dai W, Zeller C, Masrour N, et al. Promoter CpG island methylation of genes in key cancer pathways associates with clinical outcome in high-grade serous ovarian cancer. Clin Cancer Res. 2013;19:5788\u201397.","journal-title":"Clin Cancer Res"},{"key":"1886_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10549-009-0439-5","volume":"118","author":"E Barroso","year":"2009","unstructured":"Barroso E, Pita G, Arias JI, et al. The Fanconi anemia family of genes and its correlation with breast cancer susceptibility and breast cancer features. Breast Cancer Res Treat. 2009;118:655\u201360.","journal-title":"Breast Cancer Res Treat"},{"key":"1886_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0066243","volume":"8","author":"E Ribeiro","year":"2013","unstructured":"Ribeiro E, Ganzinelli M, Andreis D, et al. Triple negative breast cancers have a reduced expression of DNA repair genes. PLoS ONE. 2013;8: e66243.","journal-title":"PLoS ONE"},{"key":"1886_CR18","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ejca.2010.11.029","volume":"47","author":"M Ganzinelli","year":"2011","unstructured":"Ganzinelli M, Mariani P, Cattaneo D, et al. Expression of DNA repair genes in ovarian cancer samples: biological and clinical considerations. Eur J Cancer. 2011;47:1086\u201394.","journal-title":"Eur J Cancer"},{"key":"1886_CR19","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1470-2045(19)30684-9","volume":"21","author":"J Mateo","year":"2020","unstructured":"Mateo J, Porta N, Bianchini D, et al. Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial. Lancet Oncol. 2020;21:162\u201374.","journal-title":"Lancet Oncol"},{"key":"1886_CR20","doi-asserted-by":"publisher","first-page":"13145","DOI":"10.1002\/cam4.5997","volume":"12","author":"F Ciardiello","year":"2023","unstructured":"Ciardiello F, Bang YJ, Cervantes A, et al. Efficacy and safety of maintenance therapy with pamiparib versus placebo for advanced gastric cancer responding to first-line platinum-based chemotherapy: phase 2 study results. Cancer Med. 2023;12:13145\u201354.","journal-title":"Cancer Med"},{"key":"1886_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27\u201340.","journal-title":"Lancet"},{"key":"1886_CR22","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/annonc\/mdy540","volume":"30","author":"N Boku","year":"2019","unstructured":"Boku N, Ryu MH, Kato K, et al. Safety and efficacy of nivolumab in combination with S-1\/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric\/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4). Ann Oncol. 2019;30:250\u20138.","journal-title":"Ann Oncol"},{"key":"1886_CR23","doi-asserted-by":"publisher","first-page":"4412","DOI":"10.3748\/wjg.v24.i38.4412","volume":"24","author":"JP Huang","year":"2018","unstructured":"Huang JP, Lin J, Tzen CY, et al. FANCA D1359Y mutation in a patient with gastric polyposis and cancer susceptibility: a case report and review of literature. World J Gastroenterol. 2018;24:4412\u20138.","journal-title":"World J Gastroenterol"},{"key":"1886_CR24","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s12032-010-9590-4","volume":"28","author":"IS Choi","year":"2011","unstructured":"Choi IS, Lee HS, Lee KW, et al. Biomarker analysis in patients with advanced gastric cancer treated with S-1 plus cisplatin chemotherapy: orotate phosphoribosyltransferase expression is associated with treatment outcomes. Med Oncol. 2011;28:991\u20138.","journal-title":"Med Oncol"},{"key":"1886_CR25","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1007\/s00595-020-02048-w","volume":"50","author":"T Namikawa","year":"2020","unstructured":"Namikawa T, Yokota K, Tanioka N, et al. Systemic inflammatory response and nutritional biomarkers as predictors of nivolumab efficacy for gastric cancer. Surg Today. 2020;50:1486\u201395.","journal-title":"Surg Today"},{"key":"1886_CR26","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s12328-021-01384-9","volume":"14","author":"T Namikawa","year":"2021","unstructured":"Namikawa T, Shimizu S, Yokota K, et al. Isolated adrenocorticotropic hormone deficiency induced by nivolumab treatment for advanced gastric cancer. Clin J Gastroenterol. 2021;14:988\u201393.","journal-title":"Clin J Gastroenterol"},{"key":"1886_CR27","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1111\/jgh.16064","volume":"38","author":"J Wen","year":"2023","unstructured":"Wen J, Shen H. Trend of gastric cancer incidence and death rate in adolescents and young adults: a retrospective cohort study based on the surveillance, epidemiology, and end results (SEER) database. J Gastroenterol Hepatol. 2023;38:393\u2013403.","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01886-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12328-023-01886-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-023-01886-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,31]],"date-time":"2024-01-31T16:13:52Z","timestamp":1706717632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12328-023-01886-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["1886"],"URL":"https:\/\/doi.org\/10.1007\/s12328-023-01886-8","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"type":"print","value":"1865-7257"},{"type":"electronic","value":"1865-7265"}],"subject":[],"published":{"date-parts":[[2023,11,7]]},"assertion":[{"value":"8 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Tsutomu Namikawa, Tomoki Tanaka, Masato Utsunomiya, Keiichiro Yokota, Masaya Munekage, Hiromichi Maeda, Hiroyuki Kitagawa, Yusuke Kurioka, Hironaga Satake, Michiya Kobayashi, Kazuhiro Hanazaki, and Satoru Seo declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures were performed in accordance with the ethical standards of the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human rights"}},{"value":"Informed consent was obtained from the patient before inclusion in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}